Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Latest news

12/6/2018 RNC Pharma Database Update: Pharmaceutical Drug Production in Russia (October 2018)

Between January and October 2018, Russia produced 276.2 mln RUB worth of pharmaceutical drugs (dispatch prices, VAT included), which is in monetary terms 1.9% higher than that of the same period of 2017. The positive dynamics are mostly due to the active work of manufacturers. In physicals terms though, Russia produced 3.3 bln units of pharmaceuticals, which is 9.4% lower than that of the same period of 2017.

11/16/2018 Database Update: API Import to Russia (September 2018)

Between January and September 2018, Russia imported 68.9 bln RUB worth of APIs (free circulation prices, VAT included), which is in monetary terms 26.8% higher than that of the same period of 2017. In physical terms, the dynamics are -8.5%, and the imported volume is 8,300 tons.

11/14/2018 Database Update: Import of Veterinary Drugs, Feed, Feed Supplements and APIs to Russia (September 2018)

Between January and September 2018, Russia imported 47.4 bln RUB worth of veterinary products (free circulation prices), which is in monetary terms 15.3% higher than that of the same period of 2017. The import of feed supplements amounted to 27.3 bln RUB, with a 16.9% increase. The import of veterinary drugs amounted to 18.7 bln RUB, with a 13.6% increase. The import of veterinary APIs amounted to 1.5 mln RUB, with a 15% increase.

11/13/2018 Database Update: Pharmaceutical Drug Import to Russia (September 2018)

Between January and September 2018, Russia imported 376.6 bln RUB worth of ready-made pharmaceutical drugs (free circulation prices), which is in monetary terms 1% higher than that of the same period of 2017, and 81.1 bln RUB worth of in-bulk drugs, which is 16% higher than that of the same period of 2017. The total dynamics in monetary terms are +3.3%.

11/12/2018 Rating of Russian Pharmaceutical Distributors (Q1-Q3 2018)

Between January and September 2018, there was not any major changes in the ranking of the top pharmaceutical distributors, except for the top places. The first three places have changed, with Puls having reached first place after quite a struggle. The changes are not that surprising, which we discussed in our previous review (Q1 – Q2 results).

All news [121]

Our competences

RNC Pharma is focused on providing information about development trends of Russian pharmaceutical market infrastructure component. Our experts also provide services on strategic marketing, such as forecasting, business planning, etc.